ICUI
ICU Medical, Inc.NASDAQHealthcare$123.31-1.53%ClosedMarket Cap: $3.04B
As of 2026-04-06
Valuation
P/E (TTM)
4159.23
PEG
41.34
P/B
1.43
P/S
1.36
EV/EBITDA
13.88
DCF Value
$-4.86
FCF Yield
2.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.8%
Operating Margin
2.8%
Net Margin
0.0%
ROE
0.0%
ROA
0.0%
ROIC
0.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $540.3M | 37.4% | $25.2M | $-15.7M | $-0.64 | — |
| FY 2025 | $2.23B | 36.8% | $107.0M | $732.0K | $0.03 | — |
| Q3 2025 | $537.0M | 37.4% | $13.7M | $-3.4M | $-0.14 | — |
| Q2 2025 | $548.9M | 37.9% | $10.6M | $35.3M | $1.43 | — |
| Q1 2025 | $604.7M | 34.7% | $12.9M | $-15.5M | $-0.63 | — |
| Q4 2024 | $629.8M | 36.1% | $37.7M | $-23.8M | $-0.97 | — |
| FY 2024 | $2.38B | 34.6% | $43.0M | $-117.7M | $-4.83 | — |
| Q3 2024 | $589.1M | 34.8% | $8.2M | $-33.0M | $-1.35 | — |
| Q2 2024 | $596.5M | 34.8% | $7.7M | $-21.4M | $-0.88 | — |
| Q1 2024 | $566.7M | 32.7% | $-10.7M | $-39.5M | $-1.63 | — |
| Q4 2023 | $587.9M | 29.2% | $-12.2M | $-17.1M | $-0.71 | — |
| FY 2023 | $2.26B | 32.8% | $22.8M | $-29.7M | $-1.23 | — |